
Vladimir Badmaev, MD, 1975 class, Medical Academy Bialystok (AMB), Poland; PhD, 1978, in immunopharmacology (AMB). Clinical and anatomical pathology at Kings County Hospital, New York, and Downstate Medical Center, New York, USA (1982-1985).
His lifelong work has been to integrate traditional Indo-Tibetan knowledge and science-derived pharmacology, developing a new generation of AI-based drugs, which he describes as the Interactive Nutrient Process (INP). www.BadmaevTradition.com
VP Medical&Scientific Affairs of Sabinsa Corporation 1995 – 2008, runner-up or recipient of 4 New Jersey R&D Council Thomas Alva Edison Awards. R&D of C3Complex ®, Bioperine®, Citrin®, Gugulipid ®, SeleniumSelect ®, Lactospore ®. VP Medical&Scientific Affairs at PLThomas Inc. 2008 – 2012. R&D of Xanthigen ®, RhodioLife®, Zembrin®, 5-Loxin®. Head R&D at NattoPharma 2012 – 2015. R&D of MenaQ7®.
President of American Medical Holdings Inc. (2009-present); developed Adaptrin®, GreenSelenium®, TurmericImmune®, Serenity-151, Vigor-149, SlimTrym®, FB3®; currently developing a pharma compound based on a small-molecule phenolic from ginger, 6-shogaol, for the management of early-stage myelodysplastic syndromes (MDS). The 6-Shogaol US patent, No.: US 10,864,174 B2 (2017) and 11 related patents worldwide (2017-2024), including those in Australia, South Africa, China, South Korea, Japan, Brazil, Canada, Mexico, New Zealand, India, and EC.
In 1999, Dr. Badmaev contributed a chapter on Tibetan medicine in Wayne Jonas’s and Jeffrey Levine’s textbook for medical students and health professionals, published by Williams & Wilkins and Lippincott (Amazon.com). In 2009, he contributed a chapter about curcuminoids to Raymond Cooper’s and Fredi Kronenberg’s book on alternative treatments in medicine. Dr. Badmaev has participated in the following Medical/Scientific Societies: the International Society of Immunopharmacology (1982), the American Association of Clinical Pathologists (1983), the American Medical Association (1984), and the Research and Development Council of New Jersey (1996).